Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Manley

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Genetics|October 15, 2023
Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variantsErin Mundt, Brent Mabey, Irene Rainville, et al.
Journal of the American College of Radiology : JACR|December 25, 2016
Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic TestingEric T Rosenthal, Brent Evans, John Kidd, et al.
Human Mutation|September 7, 2019
A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somaticallyBradford Coffee, Hannah C Cox, Ryan Bernhisel, et al.
Breast Cancer Research and Treatment|January 30, 2020
High risk of breast cancer in women with biallelic pathogenic variants in CHEK2Irene Rainville, Shanell Hatcher, Eric Rosenthal, et al.
JCO Precision Oncology|September 14, 2020
Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year PeriodLisa Esterling, Ranjula Wijayatunge, Krystal Brown, et al.
JAMA|September 29, 2018
Prevalence of Variant Reclassification Following Hereditary Cancer Genetic TestingJacqueline Mersch, Nichole Brown, Sara Pirzadeh-Miller, et al.
Journal of Genetic Counseling|December 18, 2004
Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselorsAngela Trepanier, Mary Ahrens, Wendy McKinnon, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Genetics|October 15, 2023
Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variantsErin Mundt, Brent Mabey, Irene Rainville, et al.
Journal of the American College of Radiology : JACR|December 25, 2016
Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic TestingEric T Rosenthal, Brent Evans, John Kidd, et al.
Human Mutation|September 7, 2019
A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somaticallyBradford Coffee, Hannah C Cox, Ryan Bernhisel, et al.
Breast Cancer Research and Treatment|January 30, 2020
High risk of breast cancer in women with biallelic pathogenic variants in CHEK2Irene Rainville, Shanell Hatcher, Eric Rosenthal, et al.
JCO Precision Oncology|September 14, 2020
Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year PeriodLisa Esterling, Ranjula Wijayatunge, Krystal Brown, et al.
JAMA|September 29, 2018
Prevalence of Variant Reclassification Following Hereditary Cancer Genetic TestingJacqueline Mersch, Nichole Brown, Sara Pirzadeh-Miller, et al.
Journal of Genetic Counseling|December 18, 2004
Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselorsAngela Trepanier, Mary Ahrens, Wendy McKinnon, et al.
Pageof 2